← The Wire
FATENasdaq
FATE THERAPEUTICS INC
Biological Products, (No Diagnostic Substances) · CIK 1434316
Develops off-the-shelf cellular immunotherapies from engineered stem cells for broad patient access
red 8-K · 90d
$240M
Market cap
$2.42
Last close
+15.2%
1D
+12.6%
5D
5.9M
Volume
Price · last 39 sessions+34.4%
May 4L $1.73 · H $2.84Jun 29
249
Total filings
Jun 15, 2026
Last filing
12/31
Fiscal year end
10-Q10-QMay 13, 202610-Q10-QNov 13, 202510-Q10-QAug 12, 202510-Q10-QMay 13, 202510-Q10-QNov 12, 202410-Q10-QAug 13, 202410-Q10-QMay 9, 202410-Q10-QNov 8, 202310-Q10-QAug 8, 202310-Q10-QMay 3, 202310-Q10-QNov 3, 202210-Q10-QAug 3, 202210-Q10-QMay 4, 202210-Q10-QNov 4, 202110-Q10-QAug 4, 202110-Q10-QMay 5, 202110-Q10-QNov 5, 202010-Q10-QAug 5, 202010-Q10-QMay 11, 202010-Q10-QNov 5, 201910-Q10-QAug 6, 201910-Q10-QMay 7, 201910-Q10-QNov 1, 201810-Q10-QAug 6, 201810-Q10-QMay 10, 201810-Q10QNov 1, 201710-QFATE-10Q-20170630Aug 14, 201710-QFORM 10-QMay 15, 201710-QFORM 10-QNov 7, 201610-QFORM 10-QAug 8, 201610-Q10-QMay 9, 201610-Q10-QNov 3, 201510-Q10-QAug 5, 201510-Q10-QMay 7, 201510-Q10-QNov 12, 201410-Q10-QAug 12, 201410-Q10-QMay 13, 201410-Q10-QNov 13, 2013
Insider Activity
In the 90 days to Jan 9, 2026: 2 sold $17K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 9, 2026 | Tahl CindySee Remarks | Sell | 10,589 | $1.06 | $11K |
| Jan 9, 2026 | Valamehr BahramPresident and CEO | Sell | 5,190 | $1.07 | $6K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance